Your browser doesn't support javascript.
Safety and immunogenicity after 2 doses of the BNT162b2 COVID-19 vaccine in an early-phase oncology trial centre population.
Malissen, Nausicaa; Ninove, Laetitia; de Lamballerie, Xavier; André, Nicolas; Gaudy-Marqueste, Caroline.
  • Malissen N; Centre d'Essais Précoces en Cancérologie de Marseille CLIP(2), Aix Marseille University, Assistance Publique Hôpitaux de Marseille, CNRS, INSERM, CRCM, Marseille, France; Department of Dermatology and Skin Cancer, Aix-Marseille University, Assistance Publique Hôpitaux de Marseille, CNRS, INSERM, CRC
  • Ninove L; Unité des Virus Émergents (UVE: Aix-Marseille Univ-IRD 190-Inserm 1207), Marseille, France.
  • de Lamballerie X; Unité des Virus Émergents (UVE: Aix-Marseille Univ-IRD 190-Inserm 1207), Marseille, France.
  • André N; Centre d'Essais Précoces en Cancérologie de Marseille CLIP(2), Aix Marseille University, Assistance Publique Hôpitaux de Marseille, CNRS, INSERM, CRCM, Marseille, France; Department of Pediatric Oncology, La Timone Children's Hospital, AP-HM, Marseille, France; Metronomics Global Health Initiative,
  • Gaudy-Marqueste C; Centre d'Essais Précoces en Cancérologie de Marseille CLIP(2), Aix Marseille University, Assistance Publique Hôpitaux de Marseille, CNRS, INSERM, CRCM, Marseille, France; Department of Dermatology and Skin Cancer, Aix-Marseille University, Assistance Publique Hôpitaux de Marseille, CNRS, INSERM, CRC
Eur J Cancer ; 156: 125-126, 2021 10.
Article in English | MEDLINE | ID: covidwho-1397326

Full text: Available Collection: International databases Database: MEDLINE Main subject: Immunogenicity, Vaccine / COVID-19 Vaccines / COVID-19 / Neoplasms Type of study: Cohort study / Observational study / Prognostic study / Randomized controlled trials Topics: Vaccines Limits: Humans Language: English Journal: Eur J Cancer Year: 2021 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Immunogenicity, Vaccine / COVID-19 Vaccines / COVID-19 / Neoplasms Type of study: Cohort study / Observational study / Prognostic study / Randomized controlled trials Topics: Vaccines Limits: Humans Language: English Journal: Eur J Cancer Year: 2021 Document Type: Article